Pharma

- Advertisement -
Ad imageAd image
Taletrectinib Moves Toward Europe Approval Review

Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…

Emeraid and Integrity Healthcare finish clinical data project

Emeraid Inc., a healthcare AI DX startup originating from the University of…

B-MAP and Ignis Explore Medical-Skynet AI for Clinics

B-MAP Inc. is pleased to announce that it has today signed a…

Eisai and Henlius Sign Japan Rights Deal for Serplulimab

Eisai and Shanghai Henlius Biotech have signed an exclusive commercialization agreement and…

Rakuten Medical and LOTTE Biologics Forge Strategic Manufacturing Alliance to Fuel Global Oncology Programs

Rakuten Medical, Inc., a biotech firm in the U.S., has partnered with…

Kura and Kyowa Report Strong KOMZIFTI AML Data

Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…

Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing

Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…

Ubie and Kameda Hospital Start AI Obesity Treatment PoC

Ubie Inc. is pleased to announce that, in collaboration with Kameda General…

Eisai Seeks Approval for Subcutaneous LEQEMBI in Japan

Eisai and its global partner Biogen have filed a new drug application…

Emeraid and Integrity Healthcare finish clinical data project

Emeraid Inc., a healthcare AI DX startup originating from the University of…

B-MAP and Ignis Explore Medical-Skynet AI for Clinics

B-MAP Inc. is pleased to announce that it has today signed a…

Eisai and Henlius Sign Japan Rights Deal for Serplulimab

Eisai and Shanghai Henlius Biotech have signed an exclusive commercialization agreement and…

Rakuten Medical and LOTTE Biologics Forge Strategic Manufacturing Alliance to Fuel Global Oncology Programs

Rakuten Medical, Inc., a biotech firm in the U.S., has partnered with…

Kura and Kyowa Report Strong KOMZIFTI AML Data

Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…

Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing

Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…

Ubie and Kameda Hospital Start AI Obesity Treatment PoC

Ubie Inc. is pleased to announce that, in collaboration with Kameda General…

Eisai Seeks Approval for Subcutaneous LEQEMBI in Japan

Eisai and its global partner Biogen have filed a new drug application…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community